
Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy (NYSE:ELAN)
This article was written by Follow I am a growth-oriented investor, conducting fundamental research. Long-term focus, independent thinking. I prefer companies with deep moats